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Abstract
Background: There is now convincing evidence that in industrialized countries therapeutic hypothermia for
perinatal asphyxial encephalopathy increases survival with normal neurological function. However, the greatest
burden of perinatal asphyxia falls in low and mid-resource settings where it is unclear whether therapeutic
hypothermia is safe and effective.
Aims: Under the UCL Uganda Women’s Health Initiative, a pilot randomized controlled trial in infants with
perinatal asphyxia was set up in the special care baby unit in Mulago Hospital, a large public hospital with ~20,000
births in Kampala, Uganda to determine:
(i) The feasibility of achieving consent, neurological assessment, randomization and whole body cooling to a
core temperature 33-34°C using water bottles
(ii) The temperature profile of encephalopathic infants with standard care
(iii) The pattern, severity and evolution of brain tissue injury as seen on cranial ultrasound and relation with
outcome
(iv) The feasibility of neurodevelopmental follow-up at 18-22 months of age
Methods/Design: Ethical approval was obtained from Makerere University and Mulago Hospital. All infants were
in-born. Parental consent for entry into the trial was obtained. Thirty-six infants were randomized either to standard
care plus cooling (target rectal temperature of 33-34°C for 72 hrs, started within 3 h of birth) or standard care
alone. All other aspects of management were the same. Cooling was performed using water bottles filled with
tepid tap water (25°C). Rectal, axillary, ambient and surface water bottle temperatures were monitored continuously
for the first 80 h. Encephalopathy scoring was performed on days 1-4, a structured, scorable neurological
examination and head circumference were performed on days 7 and 17. Cranial ultrasound was performed on
days 1, 3 and 7 and scored. Griffiths developmental quotient, head circumference, neurological examination and
assessment of gross motor function were obtained at 18-22 months.
Discussion: We will highlight differences in neonatal care and infrastructure that need to be taken into account when
considering a large safety and efficacy RCT of therapeutic hypothermia in low and mid resource settings in the future.
Trial registration: Current controlled trials ISRCTN92213707
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In the UK and other developed world settings, moder-
ate-severe encephalopathy following perinatal asphyxia
occurs in 1-2/1000 term births [1]. There are major
consequences for families and for society; approximately
25% of affected infants will die in the neonatal unit and
40% will develop cerebral palsy. Others will have long-
term neurodevelopmental deficits that result in a diffi-
cult life and lost potential [2]. Within the last decade,
therapeutic hypothermia for infants with perinatal
asphyxial encephalopathy has been studied in several
randomised controlled trials (RCTs) in industrialized
countries [3-6]. Meta-analyses of these trials show that
therapeutic hypothermia increases survival with normal
neurological function (pooled risk ratio of 1.53) with a
number needed to treat of 8 (95% confidence interval
(CI) 5 - 17) and in survivors reduces the rates of severe
disability and cerebral palsy [7,8]. Therapeutic hypother-
mia under intensive care settings appears safe [7]. Ther-
apeutic hypothermia is now widely offered to
moderately or severely asphyxiated infants in high-
income countries [9]. In 2010 in the UK the National
Institute for Health and Clinical Excellence (NICE)
endorsed Therapeutic Hypothermia with Intracorporeal
T e m p e r a t u r eM o n i t o r i n gf o rH y p o x i cP e r i n a t a lB r a i n
Injury (see website: http://www.nice.org.uk/nicemedia/
live/11315/48809/48809.pdf)
The global burden of disease estimates indicate that
perinatal asphyxia is a very significant problem in low
and mid-resource settings [10]; for example in sub-
Saharan Africa, neonatal encephalopathy related to peri-
natal asphyxia is ~10-20 times more common than in
the developed world [11]. Globally, perinatal asphyxia is
responsible for 42 million disability life adjusted years,
double that due to diabetes and three quarters of that
due to HIV/AIDS [10]. Almost one quarter of the
world’s 4 million annual neonatal deaths are caused by
perinatal asphyxia [12] and 99% of these deaths occur in
low and mid-resource settings. These intrapartum-
related deaths account for as many deaths as does
malaria but they are not addressed in any global health
policy.
A safe and effective therapy for neonatal encephalopa-
thy appropriate for low resource settings is likely to ben-
efit millions of infants and families. There are, however,
several compelling reasons why the efficacy and safety
data on therapeutic hypothermia from high-income
countries cannot be simply extrapolated to mid and low
resource settings. For example (i) brain injury may be
already established due to multiple antenatal insults (e.g.
maternal malnutrition and other co-morbidities), (ii)
prolonged obstructed labour, long delays in carrying out
emergency caesarean sections, and lack of effective
resuscitation and networks for neonatal transport may
all reduce or nullify the therapeutic window for
hypothermia [13]. (iii) the incidence and profile of peri-
natal infections in this population is different. Cooling
in the presence of infection might even be deleterious as
hypothermia may impair innate immune function,
including neutrophil migration and function [14],
although it is reassuring that the neonatal cooling trials
from industrialized countries did not show a higher inci-
dence of sepsis in cooled infants. It is important to note
that hypothermia during sepsis in adult patients has
been associated with increased mortality and higher cir-
culating levels of TNF-a AND IL-6 [15]. One explana-
tion for the higher morbidity and mortality associated
with hypothermia in some clinical settings may be the
prolongation of NF-KB activation and altered cytokine
gene expression known to occur with moderate
hypothermia [16]. Furthermore, there is convincing
experimental [17,18] and epidemiological evidence
[19,20] suggesting that a ‘dual hit’ of infection and
ischaemia results in disproportionately more severe
brain injury and increases in the risk of cerebral palsy. It
is likely that this ‘dual hit’ is one of the factors responsi-
ble for the poorer neurological outcome reported from
low and mid-resource settings [21] and it is not known
if therapeutic hypothermia would be neuroprotective in
such situations. (iv) cooling may be unsafe in the pre-
sence of meconium aspiration and pulmonary hyperten-
sion where facilities for advanced multi-organ support
may not be available; (v) the benefits of cooling may
only be achieved in units with optimal neurological
monitoring which may not be possible in low income
settings. (vi) cooling equipment used in high income
countries is expensive, requires maintenance support
and has ongoing costs. There is therefore an important
need for validation of ‘low tech’, safe and economical
cooling methods.
U g a n d aw a sc h o s e na sa no p t i m a ls i t ef o rt h ep i l o t
study because of the long tradition of research at
Mulago Hospital and Makerere University. In 2006 the
UCL Uganda Women’s Health Initiative was set up
between UCL and Mulago Hospital, Makerere Univer-
sity and Hospice Africa. Ten projects related to women’s
health were set up under the Uganda Women’s Health
initiative. One of the neonatal projects initially focused
on training midwives in neonatal resuscitation, however
MN was very keen to help the large number of infants
with perinatal asphyxia admitted to the special care
baby unit at Mulago each week. We set up a pilot ran-
domized trial of therapeutic hypothermia in Mulago
Hospital, Uganda to determine the feasibility of a larger
RCT in this setting.
The aims of the pilot study were to determine:
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Page 2 of 11(i) The feasibility of achieving consent, neurological
assessment, randomisation and whole body cooling
to a core temperature 33-34°C using a ‘low tech’
cooling method (water bottles) (already briefly
reported [22])
(ii) The temperature profiles of encephalopathic
infants randomized to standard care or standard
care plus therapeutic hypothermia (already briefly
reported [22])
(iii) The pattern, severity and evolution of brain tis-
sue injury as seen on cranial ultrasound and relation
with outcome
(iv) The feasibility of neurodevelopmental follow-up
at 18-22 months of age
Methods/design
Study Design
Ethical Approval was obtained from the Ethics Commit-
tees of the Medical School, Makerere University and
Mulago Hospital.
Training and teaching Ugandan staff
NR, DA, CH and FC spent 2 weeks on the neonatal unit
at Mualgo Hospital training the neonatal unit doctors
and nurses about the background to the study, use of
equipment, data recording and examination of patients.
Six nurses were chosen as study nurses; their responsi-
bilities included recording demographic and physiologi-
cal data, changing water bottles and swaddling with
blankets as required to maintain the rectal temperature
within target range, general nursing care and support
for the families. The nurses also recruited babies and
obtained informed consent There were clear protocols
and algorithms for recruitment of patients (Figure 1),
cooling to the target temperature (Figures 2 and Figure
3), scoring the Thompson encephalopathy score (Table
1) [23], performing the structured neurological examina-
tion [24] and guidelines for the cranial ultrasound pro-
tocol for essential views (Figure 4). Ten other helper
neonatal nurses facilitated the study by helping with the
care of the other patients on the special care baby unit.
Three senior doctors (MN, NN and JM) were responsi-
ble for taking informed consent from the family and for
performing the Thompson score for entry eligibility and
on days 1-4, the standardized and scorable neurological
examination on days 7 and 17 and the cranial ultra-
sounds on days 1,3 and 7. CH visited for 3 weeks mid-
way through the study to help with continuing training
and quality control.
Study size and overall plan
This study was intended to be a feasibility study to
assess the practical aspects of setting up a RCT of thera-
peutic hypothermia using ‘low tech’ cooling methods in
a low resource hospital setting. The study was not
intended to assess efficacy of hypothermia as a
neuroprotective treatment and was not powered for this,
although it was envisaged that the pilot study might
provide information about sample size for a future lar-
ger RCT. The aim was to recruit ~40 infants to this
study in line with previous pilot studies of cooling per-
formed in industrialized countries [25-27].
Feasibility
This high incidence of perinatal asphyxial encephalopa-
thy and feasibility of recruiting ~40 infants within 3
months was shown by a previous admissions audit at
Mulago Hospital in 2006. During this period there were
13,500 deliveries, 1,740 admissions to the neonatal unit
and 239 infants with moderate to severe neonatal ence-
phalopathy (giving an incidence of moderate to severe
neonatal encephalopathy of 18/1000 live births).
Inclusion criteria (Figure 1)
Study infants were near term or full term infants with:
1. Need for resuscitation with assisted bag and mask
ventilation after birth and/or an Apgar score of <6 at 5
minutes (10 minutes if available)
2. Abnormal Thompson neonatal encephalopathy assess-
ment score of >5 between 30 min and 3 h of age [20].
Exclusion criteria (Figure 1)
1. <36 weeks gestation or birthweight <2000 g
2. Imminent death anticipated at the time of assess-
ment for eligibility
3. >3 h of age at study entry
4. Major malformations
5. Symptomatic infection
6. Outborn
7. Families who live >20 km away from Mulago
Hospital
8. Parents who did not speak or understand either
English or Luganda or any parent who does not under-
stand the study.
Consent
Informed consent was obtained using an information
sheet available in either English or Lugandan. The study
doctor met with the parents in the intervention period
to ensure they understand the study procedures and
continue to consent to participation in the study [28].
Randomization
Randomization was by sealed envelopes in eligible
infants up to a total of 4 study infants at a time. The
maximum number of infants we were able to study at
any one time was 4 due to the limited number of avail-
able data loggers and the need to keep the workload to
an acceptable level.
Standard care group Infants receiving standard care
were cared for in cots according to usual hospital clini-
cal practice. Standard care at Mulago Hospital Neonatal
Unit included:
Oxygen saturation monitoring: depending on the
availability of the only pulse oximeter in the neonatal
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4-12 hrly by moving the oxygen saturation monitor
from one infant to another. If an infant looked cyanotic,
supplementary nasal cannulae oxygen was given if at
least 2 recordings of a saturation <85% had been
recorded.
Blood pressure: it was not possible to measure mean
arterial blood pressure.
Temperature monitoring: Rectal, axillary, ambient and
water bottle surface temperatures were monitored con-
tinuously and stored using a 4-channel data logger
(Squirrel SQ 2020, Keison Products, Chelmsford, UK).
Is baby > 36 weeks old and has a birthweight>2000g
Yes No
Included
Was there need for resuscitation with assisted bag andmask ventilation
and/or APGAR score of <6 at 5 minutes (10 minutes if available)
No
Excluded
Included Yes
Is the neurological assessment (Thompson score) >5
Yes No
Included
Yes
No
Excluded
Was onset of regular breathing delayed 
>20min, and/or did  the infant remain apnoeic or
cyanotic, and/or had no  cardiac output
Included
Excluded
Is the baby outborn?
No Yes
Included
No
Yes
Excluded
Does the family understand 
english or luganda?
Is there any major malformation?
Included
Excluded
No Yes
Included
Is the baby more than 3 hrs old at randomisation
No Yes
Included
Yes
No
Excluded
Is there any sympto-
matic infection?
Does the family live >20km of 
radius of Mulago Hospital
Included
Excluded
No Yes
INCLUDE IN STUDY 
AND RANDOMISE
Excluded
Entry criteria for pilot feasibility and safety study of a simple, 
low cost method of whole body cooling in neonatal encephalopathy
in the Special Care Baby Unit, Mulago Hospital, Kampala
Figure 1 Entry criteria for pilot feasibility and safety study of a simple, low cost method of whole body cooling in a neonatal
encephalopathy in the Special Care Baby Unit, Mulago Hospital, Kampala.
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sheets was used to adjust the rectal temperature to
normothermia.
Administration of antibiotics: The current neonatal
unit guidelines at Mulago Hospital include administra-
tion of Ampicillin and Gentamicin to all sick infants.
Blood glucose and fluid administration: An IV cannula
was sited and 10% dextrose was given intravenously as
hourly boluses to make up 60 ml/kg/day according to
the current neonatal unit guidelines. Blood glucose was
measured every 6 h using glucose test strips (Optimum
Medisense H Blood Glucose Test strips and calibrator,
Abbott Diabetes Care Ltd, Oxon, UK).
Sedation: If infants appeared agitated or unsettled,
phenobarbitone 20 mg/kg IV was given.
Treatment of clinical seizures: administration of an
intravenous bolus of 10% dextrose. If seizures persisted
then 20 mg/kg phenobarbitone was given intravenously
and repeated if necessary.
Standard care plus cooling (Figures 2 and 3) Infants
randomized to standard care plus cooling were cared for
in exactly the same way as standard care apart from the
temperature control. Infants were nursed in a cot naked
or lightly covered with a cotton sheet. Active cooling
w a sb yp l a c i n gam a t t r e s su n d e rt h ei n f a n t-t h em a t -
tress comprised three commercially available water bot-
tles filled with tepid tap water (25°C) and covered in a
cotton sheet. The tap water temperature was fairly
stable throughout the 24 hours and generally around
22-25°C. The sheet-covered water bottles were in con-
tact with as much of the skin surface area of the infant
as possible. The target rectal temperature was 33-34°C.
The rectal, axillary, ambient and surface water bottle
temperatures were monitored continuously and stored
using the data logger. Our pre-clinical work suggested
that the bottle water wouldn e e dt ob ec h a n g e de v e r y
8-12 h [29]. If warming was required, the infant was
dressed or covered with blankets and sheets as
required. Cooling was concluded 72 hours after rando-
mization or earlier if clinical circumstances dictated.
The rectal temperature was then be allowed to rise by
no more than 0.5°C per hour to 37°C, by slowly redu-
cing the contact of the baby with the water bottles.
This was achieved by progressively removing water
How to cool (1) for pilot feasibility and safety study of a simple, low cost method 
of whole body cooling in neonatal encephalopathy in the Special Care Baby Unit, 
Mulago Hospital, Kampala
If the baby’s rectal temperature is 
> 34 ºC on admission 
Start cooling with water bottles and record 
temperature according to daily log
If rectal temp. is <33.0 ºC: add 
sheet one at a time on baby and 
check temp. again after 30’
If rectal temp. is or remains > 34 
ºC at any point of time or is not 
decreasing:
If baby is covered with blankets or sheets: 
start removing them one at the time and 
check rectal temp. again after 30’
If baby has no blankets or sheets on 
body: then change water in bottles 
and check temp. again after 30’
If rectal temp. stays <33.0 ºC, 
add blanket on baby and check 
again temperature after 30’
If the baby’s rectal temp. stays <33.0 ºC 
add a second blanket and check again 
Temp. after 30’
If baby’s rectal temp is <32.0 ºC and the 
baby is covered with blankets, remove water 
bottles, check temp. after 30’
If rectal temperature is decreasing: 
wait and monitor
temperature
blanket
sheet
Water bottles
Figure 2 How to cool (1) for pilot feasibility and safety study of a simple low cost method of whole body cooling in a neonatal
encephalopathy in the Special Care Baby Unit, Mulago Hospital, Kampala.
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Page 5 of 11bottles from beneath the baby and swaddling the baby.
All other aspects of clinical care were the same in both
groups.
Early Neurological assessment
The severity of the infant’s encephalopathy was assessed
and scored daily for the first 4 days using the Thompson
score (Table 1) [23]. A standardized neurological
examination was performed on days 7 and 17 and a
neurological optimality score calculated (the score was
adapted from the published optimality score norms -
total maximum score 34) [24,30]. This examination was
simple to teach and required that the predominant pat-
terns of posture/tone/reflex activity/movements and
behavior were circled and could be scored later [24].
How to cool (2) for pilot feasibility and safety study of a simple, low cost method 
of whole body cooling in neonatal encephalopathy in the Special Care Baby Unit, 
Mulago Hospital, Kampala
sheet
blanket
Water bottles
If the baby’s admission 
rectal temperature is   
< 34 ºC
If rectal  temp. is <33.0 ºC: add one sheet on 
baby and check temp. after 30’, do not start 
cooling with water bottles
If temp. is between 33.0-34 ºC and the baby 
is naked: don’t start water bottles yet but 
check temp. in 30’ again
If  rectal temp. is now >34, start cooling with 
water bottles and check temp. again after 30’
If baby’s rectal temp. is stable between 33.0-
34.0 monitor temp. as in daily log and do not 
start cooling with water bottles yet
If the rectal temp. stays <33.0 ºC, add one 
blanket on baby and check temp. again after 
30’
If the baby’s rectal temp. stays <33.0 ºC add 
a second blanket and check rectal temp. 
again after 30’
Only once the baby’s temp. has reached >34
ºC when baby is naked with nappy only start 
cooling with water bottles
Figure 3 How to cool (2) for pilot feasibility and safety study of a simple low cost method of whole body cooling in a neonatal
encephalopathy in the Special Care Baby Unit, Mulago Hospital, Kampala.
Table 1 Neonatal encephalopathy score [23]
Sign 0 1 2 3
Tone Normal Hyper Hypo Flaccid
Level of consciousness Normal Hyperalert, stare Lethargic Comatose
Fits Normal Infrequent <3/day Frequent >2/day
Posture Normal Fisting, cycling Strong distal flexion Decerebrate
Moro Normal Partial Absent
Grasp Normal Poor Absent
Suck Normal Poor Absent/
bites
Respiration Normal Hyperventilation Brief apnoea Apnoeic
Fontanelle Normal Full, not tense Tense
The score is derived from the clinical assessment of 9 signs. Each sign is scored from 0 to 3 and the score for each day is totalled. The higher the score the more
severely affected the infant. The maximum possible score is 22.
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Page 6 of 11Neonatal cranial ultrasound scanning for the pilot 
feasibility study of whole body cooling for neonatal 
encephalopathy at Mulago University Hospital 
Standard coronal views
Make space between the baby’s head 
and the end of the cot so you can 
move the probe in all directions
Feel fontanelle, place probe gently on
Point the marker on the side of the 
probe to the right side of the baby
Standard sagittal / parasagittal views
Scan protocol
1. on admission
2. day 3 
3. day 7
Anterior coronal
interhemispheric fissure
white matter
Mid-coronal 
corpus callosum
choroid at foramen of Monro
Sylvian fissure (insula)
basal ganglia
Thalamic view at maximum 
width of the cerebellum 
Sylvian fissure (insula)
thalamus
cerebellum
lambdoid suture
Postero-lateral venticles
To show the full length
of the choroid plexus 
Posterior to the ventricles
white matter 
interhemispheric fissure
lambdoid suture
Mid-sagittal view
Corpus callosum, 3rd ventricle, 4th ventricle cerebellar vermis
Always try to be symmetrical
If you see something unusual take an image of   
it that shows it best in coronal and sagittal 
views if possible 
Always freeze and save the images
Doppler measurements
Mid-sagittal view. press C to get green box on screen
Move box over vessel, turn up gain if vessel not seen
Press PW to get spectra . Remember to change the 
scale if the spectra do not fit on the graph
Parasagittal view 1
caudothalamic notch
thalamus
choroid plexus in ventricle 
body of cerebellum
Parasagittal view 2
ventricle
thalamus
medial insula (Sylvian fiss.)
Parasagittal 3
white matter
lateral insula (Sylvian fiss.)
Anterior cerebral artery
Spectra
Turn probe so side mark points  Turn probe so side mark points 
to front (nose) of the baby to front (nose) of the baby
Figure 4 Neonatal cranial ultrasound scanning for the pilot feasibility and safety study of a simple, low cost method of whole body
cooling for neonatal encephalopathy at Mulago Hospital, Kampala
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day 7 and 17 [31].
Cranial ultrasound
A hand portable ultrasound machine (Z.one Ultra Con-
vertible Ultrasound System, 3.0 Release, Zonare Medical
Systems Inc. USA) was used in this study. Infants were
scanned within the first 24 h of admission (to determine
possible antenatal brain injury) and at 3 and 7 days.
Practical training sessions on the use of the machine
and the optimal views to be taken were undertaken with
the Uganda doctors prior to the start of the study
(Figure 4).
The ultrasound scans were analyzed according to a
graded scoring system which assessed (i) basal ganglia
and thalami (scale 0-3) and (ii) white matter; (scale of 0-
4) with 0 being normal and 4 being most abnormal and
(iii) cortex (scale 0-3) (Table 2). Any other abnormality
was noted e.g. cortical abnormality, sub-ependymal or
choroidal cysts, lenticulostriate vasculopathy or other
calcification, ventricular size evidence of atrophy. The
scores for each brain area on the latest cranial ultra-
sound scan were added to give a total cranial ultrasound
score.
To determine the incidence of abnormalities seen on
cranial ultrasound in a population of low-risk African
babies, ~100 newborn infants on the postnatal ward
underwent a scan using the standard 11 views as soon
as possible after birth [32].
Reporting procedures for adverse events
Any adverse events (especially if serious and/or unex-
pected) occurring during the study whether or not
attributed to the study intervention were reported in a
timely manner following local regulatory procedures.
Neurodevelopmental follow-up
Where possible a health visitor took the family home so
that the house location was known for subsequent tra-
cing if no address available. Mobile phone numbers and
the village where the family lived were recorded. Con-
tact was kept as far as possible with the family when
they returned to the hospital for the childhood immuni-
zations at the following ages:
6 weeks, 10 weeks, 14 weeks: DPT OPV vaccines
6 months, 9 months: measles vaccine
12 months: measles vaccine.
No neurodevelopmental assessment was performed at
these ages, but the family were seen by MN and health
concerns could be discussed and advice given.
Neurodevelopmental assessment was performed by FC
and CH at 18-22 months using the Griffiths develop-
mental quotient [33], neurological examination and
assessment of gross motor function (GMFS). Head cir-
cumference was measured [31]. Local health workers
with experience in neurological assessment of newborn
infants helped with communication in the local lan-
guage. The Griffiths developmental quotient was chosen
for this study as it has been standardized [34] and vali-
dated in a multiracial South African setting, and used
for assessment of outcome [23]. The infant neurological
exam can be scored as a record of motor abilities
[35,36]; the gross motor function classification gives
functional motor outcome [37,38] and is a standardized
scale recognized world-wide for this purpose.
Intact survival was defined as all of DQ >84, no neu-
romotor impairment (neurological exam score ≥73 and
GMFCS ≤I), normal vision and hearing on clinical
examination.
Statistical analysis
Demographic factors and clinical characteristics were
summarized with counts (percentages) for categorical
variables, mean (standard deviation [SD]) for normally
distributed continuous variables or median (interquartile
or entire range) for other continuous variables. The
temperature data from the standard care and standard
care plus therapeutic hypothermia groups were com-
pared using t-tests. The Thompson scores, the neurolo-
gical exam scores at 17 days and the cranial ultrasound
scores were compared with neurodevelopmental out-
come at 18-22 months using appropriate regression ana-
lysis that will allow for repeated measures.
Results
Partial data from this trial have been reported briefly
elsewhere [22]. There were three main points reported
in this correspondence: (i) Therapeutic hypothermia
with whole body cooling using a low tech, low cost cool-
ing device (water bottle filled with tepid tap water form
the neonatal unit) is feasible in a low resource setting. (ii)
Table 2 Cranial ultrasound scoring system for basal ganglia, white matter and cortex
Score Basal ganglia and thalamus White matter Cortex
0 Normal Normal Normal
1 Internal capsule seen Mildly echogenic patchy parietal echogenicity Focal sulcal highlighting
2 Mild - swollen and/or small focal unilateral abnormality More diffuse parieto-temporal echogencity Diffuse sulcal highlighting
3 Clearly demarcated focal bilateral echodensity Diffuse white matter echogenicity Cortical echogenicity and thickening
4 - Cystic changes
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hypothermic for a mean of 15.6 (standard deviation 14.6)
h after birth in this setting where only swaddling and
gloves filled with hot water are used to keep babies
warm. Such passive cooling in term babies with perinatal
asphyxia was first described some 50 years ago; babies
with ‘asphyxia’ (defined as a failure to establish respira-
tion within 3 min of birth) were 2°C cooler than non-
asphyxiated infants for up to 16 h after birth [39]. This
phenomenon may be due to impairment in non-shivering
thermogenesis in asphyxiated infants, which is controlled
centrally by the hypothalamus. Larger trial sizes might be
required in this setting due to dilution of the hypother-
mic effect in the cooled group by the standard care
group. Such “passive” cooling in the standard care group
in this setting where the only method of re-warming was
swaddling differs to the developed world trials where at
least one third of the standard care infants had an ele-
vated core temperature during the first 3 days [4,40]; (iii)
Higher mortality was seen in the cooled vs the standard
care group (risk ratio: 5.0 (95% confidence interval (CI)
0.7-37)[8], absolute difference: 0.267 (95% CI 0.029,
0.505). More infants with severe neonatal encephalopathy
were randomized to the cooled group, which could
explain the excess deaths; nevertheless the possibility of
infection related deaths can’t be excluded, as there were
no facilities for infection screening at the time. Impor-
tantly, although the study was not powered to look at
safety or efficacy, these findings underline the importance
of exerting caution in the application of therapeutic
hypothermia in low and mid resource settings where the
patient risk factors and environment are very different.
Discussion
Cranial ultrasound, neurological assessment and
neurodevelopmental outcome
Cranial ultrasound has been used extensively in neonatal
practice in the developed world, since it is a convenient
technique to visualize the neonatal brain through the
anterior fontanelle serially without moving or disturbing
the patient. Cranial ultrasound is helpful to exclude
structural abnormality suggesting metabolic and other
diagnoses, detect calcification and cysts suggestive of
viral infection and detect atrophy suggestive of long
standing damage. It will also identify cerebral haemor-
rhage. Sequential observation of the evolution of injury
following a hypoxic ischaemic insult at birth is helpful
for defining the pattern and severity of lesions [41],
although MRI is the imaging modality of choice to accu-
rately define the pattern and severity of injury and prog-
nosticate outcome [42,43].
Access to MRI is not possible in most low resource
hospital settings. In this proposed study, serial cranial
ultrasound studies will provide some evidence about the
incidence of established injury and the evolving pattern
and severity of injury in relation to the outcome. Cranial
ultrasound is able to provide some very useful informa-
tion on the pattern and severity of brain injury following
perinatal asphyxia - for example a clear and persistent
abnormality of the thalami and basal ganglia on cranial
ultrasound correlates with MRI findings, which indicate
a poor prognosis [44]. Other patterns of brain injury
such as the watershed injury are, however, more difficult
to detect on cranial ultrasound.
This is the first study of therapeutic hypothermia in a
low resource setting that will include detailed cranial
ultrasound imaging, have a comparative control or typi-
cal population [32] and a neonatal neurological assess-
ment in the 3
rd week after birth and at 18-22 months.
Cooling in low and mid resource settings
In early 2000 when therapeutic hypothermia was being
considered as a therapy in industrialized countries,
initial studies consisted of pilot feasibility studies in ~40
patients [25-27]. These pilot studies were necessary
before moving onto large RCTs in industrialized coun-
tries [3,4,6]. We suggest that the same progression is
needed in both low and mid-resource settings.
This small pilot study suggests that in settings such as
Uganda, future studies need to focus on identifying risk
factors for NE (particularly the role of perinatal infec-
tion in the aetiology and outcome of NE); we are cur-
rently engaged in such case controlled studies at
Mulago Hospital. In such low resource settings with
high rates of neonatal mortality it may be inappropriate
to implement cooling without acceptable standards of
antenatal care, delivery, resuscitation, respiratory man-
agement and infection control; effective dissemination of
knowledge of best clinical practice may bring about
greater reduction in asphyxia related mortality and mor-
bidity initially [10]. Once these practices are introduced
and maintained, clinical trials may be the next stage for
a more sustained long-term improvement in neonatal
outcome.
In mid resource settings and especially in those with a
good infrastructure for resuscitation, neonatal care and
follow-up, such as in parts of Asia and South America, a
measured and careful approach is needed to ensure that
the highest quality trials of safety and efficacy of thera-
peutic hypothermia are performed. It is possible that
unless a trial is performed that is relevant to mid
resource settings, there will be a creeping, uncertain
introduction of hypothermia, with constant worries
regarding residual safety concerns [45]. Furthermore,
given the sheer magnitude of the problem of perinatal
asphyxia and NE worldwide [12], the establishment of
an effective and safe therapy would have a high impact
on medical practice throughout the world, save lives
Robertson et al. Trials 2011, 12:138
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Page 9 of 11and reduce the burden on our societies. In 2009, we
performed a cooling feasibility study in India [46] and
hope that a large Indian RCT of therapeutic hypother-
mia for neonatal encephalopathy can start in 2012.
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